NS-105-0500 clozapine-N-oxide 500MG
Ended Awarded
- Contract number
- HHSN267NJA21077
- Awardee
-
Enzo Life Sciences International, Inc. UEI ELAJVLXNEKN8
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,900
Award facts
- Contract value
-
- $3,900.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN267NJA21077?
HHSN267NJA21077 was awarded to Enzo Life Sciences International, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on April 6, 2006.
How much is contract HHSN267NJA21077 worth?
The government has obligated $3,900 on HHSN267NJA21077.
Which agency awarded contract HHSN267NJA21077?
National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) awarded HHSN267NJA21077, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN267NJA21077 an order under another contract?
Yes. HHSN267NJA21077 is a BPA call under HHSN263200400060800B, a blanket purchase agreement.
Was contract HHSN267NJA21077 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award